Botulinum toxin therapy in medical pain disorders

Delaram Safarpour; Bahman Jabbari

doi:10.1007/978-3-030-50691-9_6

Botulinum toxin therapy in medical pain disorders

Delaram Safarpour, Bahman Jabbari

Neurology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Animal studies have shown that local injection of botulinum neurotoxins (BoNTs) reduces neuropathic pain. This effect is exerted via interfering with the function of pain transmitters and modulators at peripheral and central levels. Recent studies in humans have demonstrated an analgesic effect in several pain disorders. In this chapter, the effect of BoNT therapy in different medical, human pain syndromes is reviewed. The level of efficacy in each pain syndrome is determined according to the guidelines of the Assessment Subcommittee of the American Academy of Neurology.

Original language	English (US)
Title of host publication	Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine
Publisher	Springer
Pages	131-156
Number of pages	26
ISBN (Electronic)	9783030506919
ISBN (Print)	9783030506902
DOIs	https://doi.org/10.1007/978-3-030-50691-9_6
State	Published - Oct 6 2020

Keywords

Botulinum neurotoxin
Botulinum toxin
Neuropathic pain
Pain
Pain disorder

ASJC Scopus subject areas

General Pharmacology, Toxicology and Pharmaceutics
General Dentistry
General Veterinary
General Medicine

Access to Document

10.1007/978-3-030-50691-9_6

Cite this

@inbook{0de240c8a35e4fa8a05b347c03254d18,

title = "Botulinum toxin therapy in medical pain disorders",

abstract = "Animal studies have shown that local injection of botulinum neurotoxins (BoNTs) reduces neuropathic pain. This effect is exerted via interfering with the function of pain transmitters and modulators at peripheral and central levels. Recent studies in humans have demonstrated an analgesic effect in several pain disorders. In this chapter, the effect of BoNT therapy in different medical, human pain syndromes is reviewed. The level of efficacy in each pain syndrome is determined according to the guidelines of the Assessment Subcommittee of the American Academy of Neurology.",

keywords = "Botulinum neurotoxin, Botulinum toxin, Neuropathic pain, Pain, Pain disorder",

author = "Delaram Safarpour and Bahman Jabbari",

year = "2020",

month = oct,

day = "6",

doi = "10.1007/978-3-030-50691-9_6",

language = "English (US)",

isbn = "9783030506902",

pages = "131--156",

booktitle = "Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine",

publisher = "Springer",

}

TY - CHAP

T1 - Botulinum toxin therapy in medical pain disorders

AU - Safarpour, Delaram

AU - Jabbari, Bahman

PY - 2020/10/6

Y1 - 2020/10/6

N2 - Animal studies have shown that local injection of botulinum neurotoxins (BoNTs) reduces neuropathic pain. This effect is exerted via interfering with the function of pain transmitters and modulators at peripheral and central levels. Recent studies in humans have demonstrated an analgesic effect in several pain disorders. In this chapter, the effect of BoNT therapy in different medical, human pain syndromes is reviewed. The level of efficacy in each pain syndrome is determined according to the guidelines of the Assessment Subcommittee of the American Academy of Neurology.

AB - Animal studies have shown that local injection of botulinum neurotoxins (BoNTs) reduces neuropathic pain. This effect is exerted via interfering with the function of pain transmitters and modulators at peripheral and central levels. Recent studies in humans have demonstrated an analgesic effect in several pain disorders. In this chapter, the effect of BoNT therapy in different medical, human pain syndromes is reviewed. The level of efficacy in each pain syndrome is determined according to the guidelines of the Assessment Subcommittee of the American Academy of Neurology.

KW - Botulinum neurotoxin

KW - Botulinum toxin

KW - Neuropathic pain

KW - Pain

KW - Pain disorder

UR - http://www.scopus.com/inward/record.url?scp=85148921988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148921988&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-50691-9_6

DO - 10.1007/978-3-030-50691-9_6

M3 - Chapter

AN - SCOPUS:85148921988

SN - 9783030506902

SP - 131

EP - 156

BT - Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine

PB - Springer

ER -

Botulinum toxin therapy in medical pain disorders

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this